Rapid Micro Biosystems, Inc.

NASDAQ:RPID

Medical - Devices

Healthcare
$1.11 +1.49%

+$0.03 today

Market cap
$50.31M
Beta
1.46
P/E (TTM)
-1.5
EPS (TTM)
-$1.10
52W Low $1.66High $4.94

Volume 0.17M

Average 0.18M

RPID Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Rapid Micro Biosystems, Inc.NASDAQ: RPID

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses growth accelerates

Q1 FY2026 operating expenses of $14.22M rose 17.9% year over year, ahead of the +9.6% change in trailing-twelve-month operating expenses. Sequentially, it rose 19.7% from the prior quarter. Over 3 fiscal years it compounded at +0.2% a year.

Context

  • Operating expenses amounted to 163.8% of revenue in FY2025, down 13.8 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +17.9% holds above the trailing-twelve-month pace of +9.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$14.22M+19.7% QoQ
Last fiscal yearDec 2025
$55M+10.4% YoY
LTMMar 2026
$53.85M+9.6% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+17.9%——
1 year+10.4%——
3-year CAGR+0.2%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
55M USD
Year-over-year change
+10.4%
4-year CAGR
+8.6%

Operating Expenses vs competitors

How RPID compares with its peers on the latest reported figures

  • RPID's LTM Mar 2026 operating expenses of $53.85M is the 3rd highest of the 9 companies compared; the peer median is $42.71M.
  • Its year-over-year change of +9.6% is the 3rd highest of 9, against a peer median of +2.1%.
  • Operating expenses amounts to 156.6% of revenue for RPID, versus a peer median of 105.0%.
RPID Competitors Peer median
Operating Expenses for RPID and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RCELAVITA Medical, Inc.LTM Mar 2026$98.38M -12.5%+21.7%136.0%
OWLTOwlet, Inc.LTM Mar 2026$65.53M +7.1%-17.0%61.2%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$53.85M +9.6%+0.2%156.6%
LUCDLucid Diagnostics Inc.LTM Mar 2026$47.21M +5.1%-4.0%919.6%
CGTXCognition Therapeutics, Inc.LTM Mar 2026$42.71M -20.4%+3.3%—
LNSRLENSAR, Inc.LTM Mar 2026$42.7M +16.3%+8.8%74.0%
SERASera Prognostics, Inc.LTM Mar 2026$36.51M -0.8%-7.3%64043.9%
VANIVivani Medical, Inc.LTM Mar 2026$27.68M +11.1%+8.5%—
APYXApyx Medical CorporationLTM Mar 2026$22.35M -43.7%-21.5%40.0%
Peer median (excluding RPID) $42.71M+2.1%-0.3%105.0%

Competitors are the stored peer set for RPID. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.23M17.13M22.52M28.05M33.59M
Cost of Revenue30.97M25.67M28M28.16M25.98M
Gross Profit(7.74M)(8.54M)(5.49M)(109K)7.61M
Gross Margin-33.3%-49.8%-24.4%-0.4%22.7%
Research & Development9.78M12.87M12.82M14.6M13.6M
Selling, General & Admin29.71M41.81M38.26M35.21M34.84M
Operating Expenses39.49M54.68M51.08M49.81M55M
Depreciation & Amortization1.53M2.84M3.11M3.36M3.25M
EBITDA(69.25M)(58.55M)(49.33M)(43.51M)(42.74M)
EBITDA Margin-298.1%-341.7%-219.1%-155.1%-127.3%
Operating Income(47.23M)(63.22M)(56.56M)(49.92M)(47.39M)
Operating Margin-203.3%-369.0%-251.2%-178.0%-141.1%
Interest Income01.78M4.21M3.16M1.51M
Interest Expense2.65M0001.09M
Other Income / Expenses(26.2M)1.84M4.13M3.05M309K
Income Before Tax(73.43M)(61.38M)(52.44M)(46.87M)(47.08M)
Pre-Tax Margin-316.1%-358.3%-232.9%-167.1%-140.2%
Income Tax Expense91K(576K)31K22K40K
Net Income(73.52M)(60.81M)(52.47M)(46.89M)(47.12M)
Net Margin-316.5%-354.9%-233.0%-167.2%-140.3%
EPS (Basic)(1.88)(1.43)(1.22)(1.08)(1.05)
EPS (Diluted)(1.88)(1.43)(1.22)(1.08)(1.05)
Weighted Avg Shares41.47M42.45M43.02M43.58M44.68M
Weighted Avg Shares (Diluted)41.47M42.45M43.02M43.58M44.68M

Rapid Micro Biosystems, Inc.

NASDAQ:RPID

Intrinsic Alpha fair value

Locked

Current Price

$1.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.